
Wazoku Continues Global Expansion After Strengthening Latin American Presence
The GlobeNewswire reported that Innovation scale-up Wazoku has continued its global expansion and extended its reach into Latin America with the acquisition of Colombian open innovation crowd Channge. Channge is home to the largest open innovation community in Latin America, solving strategic challenges for enterprises by channeling collective creativity
Comments Off on Wazoku Continues Global Expansion After Strengthening Latin American Presence • Read this story »
More Articles

3 Business Models That Could Bring Million-Dollar Cures to Everyone
The Harvard Business Review website noted that product classes with fundamentally new performance profiles can’t be dropped into an existing business model and expected to work. The business model — how value is created, captured, and delivered — needs to be reinvented to support the new proposition. It’s
Comments Off on 3 Business Models That Could Bring Million-Dollar Cures to Everyone • Read this story »

Open Minds for Open Innovation
The PMLive website noted that many large, successful organizations such as Apple and NASA are already embracing open innovation to stay at the top of their game. In healthcare, programs like 23andMe and PatientsLikeMe have demonstrated that this is a tangible tactic, despite the traditional need for
Comments Off on Open Minds for Open Innovation • Read this story »

Korean Drugmakers to Seek Global Partnerships
The Korea Herald website reported that South Korean pharmaceutical companies and global drugmakers came together to discuss new business partnerships and open innovation at this year’s Korea Pharma Associations Conference in Seoul. As one of the biggest pharma industry events of the year, the conference
Comments Off on Korean Drugmakers to Seek Global Partnerships • Read this story »

Data Sharing Aids Fight Against Malaria
The journal Nature reports that in the hunt for drugs that target diseases in the developing world, ‘open innovation’ is creating a buzz. Pharmaceutical companies are making entire libraries of chemical compounds publicly available, allowing researchers to rifle through them for promising drug